# FDA recall D-0312-2025

> **SUN PHARMACEUTICAL INDUSTRIES INC** · Class III · drug recall initiated 2025-03-04.

## Product

Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.

## Reason for recall

Cross Contamination

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0312-2025
- **Recalling firm:** SUN PHARMACEUTICAL INDUSTRIES INC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-03-04
- **Report date:** 2025-04-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0312-2025

## Citation

> AI Analytics. FDA recall D-0312-2025. Retrieved 2026-07-06 from https://api.ai-analytics.org/recall/D-0312-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*